Molecular imaging -: Beyond the genome:: Molecular imaging in vivo with PET and SPECT

被引:50
作者
Luker, GD
Piwnica-Worms, D
机构
[1] Washington Univ, Sch Med, Edward Mallinckrodt Inst Radiol, Mol Imaging Ctr,Lab Mol Radiopharmacol, St Louis, MO 63110 USA
[2] Washington Univ, Sch Med, Dept Mol Biol & Pharmacol, St Louis, MO 63110 USA
关键词
D O I
10.1016/S1076-6332(03)80738-9
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
引用
收藏
页码:4 / 14
页数:11
相关论文
共 91 条
[1]  
Allikmets R, 1998, CANCER RES, V58, P5337
[2]  
BAILINGER JR, 1995, Q J NUCL MED, V39, P122
[3]  
Ballinger JR, 1997, J NUCL MED, V38, P1915
[4]  
Ballinger JR, 1996, J NUCL MED, V37, P1578
[5]   TC-99(M)-SESTAMIBI AS AN AGENT FOR IMAGING P-GLYCOPROTEIN-MEDIATED MULTIDRUG-RESISTANCE - IN-VITRO AND IN-VIVO STUDIES IN A RAT BREAST-TUMOR CELL-LINE AND ITS DOXORUBICIN-RESISTANT VARIANT [J].
BALLINGER, JR ;
HUA, HA ;
BERRY, BW ;
FIRBY, P ;
BOXEN, I .
NUCLEAR MEDICINE COMMUNICATIONS, 1995, 16 (04) :253-257
[6]  
Barbarics E, 1998, CANCER RES, V58, P276
[7]   Creation of drug-specific herpes simplex virus type 1 thymidine kinase mutants for gene therapy [J].
Black, ME ;
Newcomb, TG ;
Wilson, HMP ;
Loeb, LA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (08) :3525-3529
[8]  
Blasberg RG, 1999, Q J NUCL MED, V43, P163
[9]  
Boland A, 2000, CANCER RES, V60, P3484
[10]  
Bom H. S., 1997, Journal of Nuclear Medicine, V38, p240P